Legal Framework

🇹🇷 Bu sayfayı Türkçe oku A reference page explaining the legal status of functional mushroom products in Turkey, health claim restrictions, and an international comparison. Version 1.0 — April 2026.

1. Legal Status in Turkey

Functional mushrooms (Lion's Mane, Reishi, Cordyceps, Turkey Tail, Sparassis, and others) are classified as food products under the legislation of the Republic of Turkey. Specifically:

Turkish Food Codex: Mushroom-based dry powders, tea and coffee blends are evaluated as food.
Supplementary Foods Communiqué (Communiqué No: 2013/49): Products sold in concentrated form exceeding the standard daily dose fall under this scope and require notification to the Ministry of Agriculture and Forestry.
Pharmaceutical classification: No functional mushroom product has been licensed as a medicine in Turkey.

2. Health Claim Prohibitions

According to the regulations of the Ministry of Health of the Republic of Turkey and the Advertising Board, the following expressions are strictly prohibited for food and supplementary food products:

"Treats", "cures", "prevents", "eliminates"
"Resolves the disease", "heals", "miraculous effect"
Associating a specific disease name with a product (e.g., "for cancer", "for diabetes")
Use of physician, patient, or hospital imagery
"Approved", "clinically proven" (without official authorization)

In the event of a violation, Advertising Board penalties, product recalls, and administrative fines apply. These expressions are never used in any content on mycovita.bio.

3. Permitted Statements

Within the legal framework, the following expressions may be used:

Description of a component's chemical structure (e.g., "Beta-glucan is a glucose polymer.")
Referencing in vitro and animal model studies with proper citation.
Formulations such as "is being investigated", "is discussed in the literature."
Food composition information of the mushroom (protein, B vitamin, mineral content).
Traditional use history (with ethnobotanical sources cited).

4. Wild Mushroom Foraging — Legal Warning

Collecting and selling wild mushrooms in Turkey is subject to the legislation of the General Directorate of Forestry. Collection permits, protected species, and seasonal restrictions are applicable. Regarding consumption, wild mushroom identification requires a professional mycologist — Amanita phalloides and other lethal species have visual look-alikes.

5. Children, Pregnant and Breastfeeding Mothers

Turkish legislation mandates a recommendation for physician approval for the use of supplementary foods in these groups. The statement "Consult your physician during pregnancy and breastfeeding" is required on labels.

6. Drug Interactions — Legal Disclosure

The theoretical interaction potential of functional mushrooms with anticoagulant, immunosuppressive, and hypoglycemic medications is discussed in the literature. For this reason, informing one's physician is an ethical imperative for those using chronic medication. The Drug Interactions Guide on mycovita.bio presents this literature in detail.

7. European Union — Novel Food Regulation

In the EU, under Regulation (EU) 2015/2283, foods not consumed to a "significant degree" within the EU before 15 May 1997 are classified as "Novel Food." In this case, approval from the European Food Safety Authority (EFSA) is required before they can be placed on the market.

The Novel Food status of species such as Lion's Mane and Cordyceps in the EU is contested. For this reason, the European market is excluded from MYCOVITA's international expansion strategy. Target markets: United Arab Emirates, United Kingdom, United States of America.

8. United Kingdom — FSA Framework

Post-Brexit, the UK conducts its own novel food process (Food Standards Agency). EU approvals are not automatically valid. A more flexible status exists in the UK for certain mushroom-based species, but a preliminary evaluation on a product basis is mandatory.

9. United States — FDA and Dietary Supplement Status

In the United States, functional mushrooms are sold as dietary supplements under the Dietary Supplement Health and Education Act (DSHEA, 1994). FDA pre-approval is not required, but structure/function claim restrictions apply, and the phrase "FDA approved" may not be used.

10. Japan — Approved Indications

Japan is the only country where the official health authority has granted approval to functional mushroom components. PSK (Krestin), a polysaccharide-protein complex derived from Trametes versicolor, was approved by the Japanese Ministry of Health as a chemotherapy adjuvant (1977). Lentinan is also approved in Japan as a gastric cancer adjuvant. These approvals are generally not valid outside Japan.

This page does not constitute legal advice. For specific regulatory questions, consult the Ministry of Agriculture and Forestry, the Ministry of Health, and TİTCK.

Version: 1.0 — April 2026